No Detail Found!

Effectiveness of cefotaxime sodium in combination with penicillin in the treatment of neonatal sepsis and its effect on the level of immunity in pediatric patients

Author(s)
Peini Wu Department of Neonatology, The Affiliated People's Hospital of Ningbo University,Pakistan
Zhengzheng Huang Department of Neonatology, The Affiliated People's Hospital of Ningbo University,Pakistan
Abstract
Neonatal septicemia seriously threatening the lives of pediatric patients and currently facing certain challenges in clinical treatment. This study analyzed the effectiveness of cefotaxime sodium combined with penicillin in the treatment of neonatal sepsis and the effect on immunity levels. 101 septic neonates from the Affiliated People's Hospital of Ningbo University between October 2020 and December 2023 were divided into CS and CP groups; both groups were treated with cefotaxime sodium and penicillin was added to CP group. The primary assessment was the clinical efficacy, inflammatory and immune indices of both groups. Secondary outcomes included symptom improvement time, serum procalcitonin levels and white blood cell (WBC) counts, recurrence rate, complication status and adverse reaction incidences. After treatment, the indices of both groups were compared for any significant difference with pre-treatment. The clinical efficacy, immunity indices, symptom improvement of CP group were significantly higher than CS group and inflammatory indices, serum procalcitonin levels and WBC counts, complication conditions and adverse reaction incidences were significantly lower than the CS group (P<0.05). No obvious differences of recurrence rate among both groups (P>0.05) were found. This combined therapy has a remarkable curative effect, which is worthy of popularization and use in the clinic.
Publication Details
Page(s) 2184-2193
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 6, Year: 2025

Request the full text from PASTIC

Keywords
Neonatal Sepsis, Penicillin, Inflammatory indices, Immune indices, Cefotaxime sodium
References
Al Bakoush FB,Azab AE,Yahya R .2023 .Neonatal sepsis: insight into incidence, classification, risk factors, causative organisms, pathophysiology, prognosis, clinical manifestations, complications, systemic examination and treatment. South Asian Res. J. App. Med. Sci., 5(6) : 136-157.
Bakhsh A,Moyes D,Proctor G,Mannocci F,Niazi SA .2022 .The impact of apical periodontitis, non-surgical root canal retreatment and periapical surgery on serum inflammatory biomarkers. Int. Endod. J., 55(9) : 923-937.
Beudeker CR,Vijlbrief DC,van Montfrans JM,Rooijakkers SH,Flier MVd SH .2022 .Neonatal sepsis and transient immunodeficiency: Potential for novel immunoglobulin therapies? Front Immunol. , 13 : 1016877.
Boscarino G,Romano R,Iotti C,Tegoni F,Perrone S,Esposito S S .2024 .An overview of antibiotic therapy for early-and late-onset neonatal sepsis: Current strategies and future prospects. Antibiotics, 13(3) : 250.
Celik IH,Hanna M,Canpolat FE,Pammi M .2022 .Diagnosis of neonatal sepsis: The past, present and future. Pediatr. Res., 91(2) : 337-350.
Darlow C A,da Costa R M S,Franceschi F,Sharland M,Piddock L,Das S,Hope W .2021 .Potential antibiotics for the treatment of neonatal sepsis caused by multidrug-resistant bacteria. Pediatr. Drugs, 23 : 465-484.
Dudeja S ,Indian J.,Pediatr J. .2020 .Neonatal sepsis: Treatment of neonatal sepsis in multidrug-resistant (MDR) infections: part 2. , 87(2) : 122-124.
Eichberger J,Resch E,Resch B .2022 .Diagnosis of neonatal sepsis: The role of inflammatory markers. Front. Pediatr, 10 : 840288.
Fleischmann C,Reichert F,Cassini A,Horner R,Harder T,Markwart R,Tröndle M,Savova Y,Kissoon N,Schlattmann P .2021 .Global incidence and mortality of neonatal sepsis: A systematic review and meta-analysis. Arch. Dis. Child., 106(8) : 745-752.
Fuchs A,Bielicki J,Mathur S,Sharland M and Van Den Anker JN .2018 .Reviewing the WHO guidelines for antibiotic use for sepsis in neonates and children. Paediatr Int. Child. H., 38 : S3-S15.
Garrido F,Allegaert K,Arribas C,Villamor E,Raffaeli G,Paniagua M,Cavallaro G,Group EAS G .2021 .Variations in antibiotic use and sepsis management in neonatal intensive care units: A European survey. Antibiotics, 10(9) : 1046.
Glaser MA,Hughes LM,Jnah A,Newberry D A .2021 .Neonatal sepsis: A review of pathophysiology and current management strategies. Adv. Neonatal Care, 21(1) : 49-60.
Hayes R,Hartnett J,Semova G,Murray C,Murphy K,Carroll L,Plapp H,Hession L,O'Toole J and McCollum D .2023 .Neonatal sepsis definitions from randomised clinical trials. Pediatr. Res., 93(5) : 1141-1148.
Hile GB,Musick KL,Dugan AJ,Bailey AM,Howington G .2020 .Occurrence of hyperbilirubinemia in neonates given a short-term course of ceftriaxone versus cefotaxime for sepsis. J. Pediatr Pharmacol, 26(1) : 99-103.
Kim F,Polin RA,Hooven TA .2020 .Neonatal sepsis. BMJ, 371 : m3672.
Korang SK,Safi S,Gluud C,Lausten-Thomsen U,Jakobsen JC .2019 .Antibiotic regimens for neonatal sepsis - A protocol for a systematic review with metaanalysis. Systematic Reviews, 8(1) : 306.
Korang S K S,Nava C,Gordon A,Gupta M,Greisen G,Lausten-Thomsen U,Jakobsen JC .2021 .Antibiotic regimens for early-onset neonatal sepsis. Cochrane DB Syst. Rev., : 13837.
Li T,Dong G,Zhang M,Hu Z,Xie Y,Wang B,Xu B Y .2020 .Association of neutrophil-lymphocyte ratio and the presence of neonatal sepsis. J. Immunol. Res., : 7650713.
Longardt A C,Piening B,von Weizsacker K,Dame C,Bührer C,Garten L C .2020 .Screening for thirdgeneration cephalosporin-resistant bacteria reduces the incidence on late-onset sepsis and antibiotic use in neonates. , 232(04) : 203-209.
Luo J,Chen C,Li Q C .2020 .White blood cell counting at point-of-care testing: A review. Electrophoresis, 41 : 1450-1468.
Mariani M,Parodi A,Minghetti D,Ramenghi LA,Palmero C,Ugolotti E,Medici C,Saffioti C,Castagnola E .2022 .Early and late onset neonatal sepsis: Epidemiology and effectiveness of empirical antibacterial therapy in a III level neonatal intensive care unit. Antibiotics, 11(2) : 284.
Mukhopadhyay S,Wade KC,Puopolo KM .2019 .Drugs for the prevention and treatment of sepsis in the newborn. Clin. perinatol., 46(2) : 327.
Nyenga AM,Mukuku O,Wembonyama SO .2021 .Neonatal sepsis: A review of the literature. Theory Clinical Practice in Pediatrics, 3 : 94-101.
Ogundare E,Akintayo A,Aladekomo T,Adeyemi L,Ogunlesi T,Oyelami O .2019 .Presentation and outcomes of early and late onset neonatal sepsis in a Nigerian Hospital. , 19(3) : 2390-2399.
Popescu CR,Cavanagh MM,Tembo B,Chiume M,Lufesi N,Goldfarb DM,Kissoon N,Lavoie PM .2020 .Neonatal sepsis in low-income countries: epidemiology, diagnosis and prevention. Expert Rev. Anti-infe, 18(5) : 443-452.
Procianoy RS,Silveira RC .2020 .The challenges of neonatal sepsis management. J. Pediat-Brazil, 96(suppl 1) : 80-86.
Qian C,Zhou M,Cheng F,Lin X,Gong Y,Xie X,Li P,Li Z,Zhang P .2020 .Development and multicenter performance evaluation of fully automated SARS-CoV-2 IgM and IgG immunoassays. Clin. Chem. Lab Med, 58(9) : 1601-1607.
Rallis D,Giapros V,Serbis A,Kosmeri C,Baltogianni M C .2023 .Fighting antimicrobial resistance in neonatal intensive care units: rational use of antibiotics in neonatal sepsis. Antibiotics, 12(3) : 508.
Rohatgi S,Dewan P,Faridi MMA,Kumar A,Malhotra R K and Batra P A .2017 .Seven versus 10 days antibiotic therapy for culture‐proven neonatal sepsis: A randomised controlled trial. J. Paediatr Child, 53(6) : 556-562.
Shane AL,Sánchez PJ,Stoll BJ .2017 .Neonatal sepsis. The Lancet, 390(10104) : 1770-1780.
Shang Z,Wu Y,Lv D,Zhang W,Liu W,Van den Anker J,Xu Y,Zhao W .2022 .Optimal dose of cefotaxime in neonates with early-onset sepsis: A developmental pharmacokinetic model-based evaluation. Front Pharmacol, 13 : 916253.
Shrivastava P,Gothalwal R,Gandhi P .2023 .Therapeutic strategies to ameliorate antibiotic resistance and host-inflammation response in sepsis: An innovative approach. Curr. Clin. Microbiol, 10(3) : 85-98.
Taneri PE,Biesty L,Kirkham JJ,Molloy EJ,Polin RA,Branagan A,Kawaza K,Daly M,Wynn J L and Bonnard LN .2025 .Proposed core outcomes after neonatal sepsis: A consensus statement. JAMA Netw Open, 8(2) : e2461554-e2461554.
Weissman SJ,Stoll B .2021 .Ampicillin and gentamicin in infants with suspected sepsis: Long live amp and gent-but for how long? JAMA pediatrics. , 175(2) : 131-132.
Yuan S,Zheng N,Zheng W,Jiang Q,Qiao B,Jing H,Li Y,Qi X,Cao W,Song S W .2021 .Analytical evaluation of Reebio procalcitonin latex-enhanced immunoturbidimetric assay on the HITACHI Labospect 008AS. Clin. Chem. Lab Med, 59(1) : e23-e26.
Zhang F .2020 .Efficacy of cefotaxime combined with gamma globulins on C-reactive protein and procalcitonin in neonatal sepsis. Cell Mol. Biol, 66(2) : 172-176.
Zwiri AM,Ahmad WMAW,Asif JA,Phaik KS,Husein A,Kassim NK,Ab-Ghani Z .2022 .A randomized controlled trial evaluating the levels of the biomarkers hs-CRP, IL-6 and IL-8 in patients with temporomandibular disorder treated with LLLT, traditional conservative treatment and a combination of both. Int. J. Environ. Res. Public Health, 19(15) : 8987.
0

Citations

0

Downloads

79

Views